The crisis has highlighted the benefits of streamlined regulation and innovation in areas such as telemedicine and digital health technologies.<\/strong><\/p>\nThe WELL ETF creator said: \u201cTech companies will play a bigger role in meeting the need for greater transparency of data and individual electronic health records. Trends to watch include accelerated development of The Individual Patient Record, as health-care companies build data registries. Also, the use of wearables and other consumer-facing technology may increase post-pandemic, integrating data from these devices with individual medical records.\u201d<\/p>\n
The HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL)<\/strong> is a UCITS compliant Exchange Traded Fund which is listed on the LSE, XETRA, SIX and Borsa Italiana. It tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index (Net Total Return), an index designed to measure the performance of large, mid and small-capitalisation companies primarily listed on an exchange in Developed and Emerging Markets that are involved in the Advanced Life Sciences & Smart Healthcare sector. The WELL fund saw growth of 23.98% in the last 3 months, and for the last 12 months it has increased in value by 18.77%. WELL\u2019s NAV reached an all-time high of $9.41 on Friday 3rd July (Source: Bloomberg).<\/p>\nRe-balance<\/strong><\/p>\nWELL underwent a re-balance on Tuesday 20th June with 10 new additions and 5 deletions. The new additions represent a diverse group covering the following subthemes \u2013 Genome Sequencing, Biological Engineering, Robotics, Healthcare Trackers, Medical Devices, Neuroscience and Bioinformatics.<\/p>\n
Medical devices remain the largest subtheme in the WELL ETF with a 54% weighting – followed by Biological Engineering (25%), Neuroscience (7%), Genome Sequencing (6%) and Robotics (5%).<\/p>\n
Key themes in the healthcare sector:<\/strong><\/p>\nGinsberg has identified several key themes that will support further growth in the healthcare innovation sector:<\/p>\n
Medical device and product manufacturers<\/p>\n
Supply constraints are providing a boon to medical device and product manufacturers, particularly those focused on PPE & devices related to the pandemic (e.g., gloves, masks, respirators.<\/p>\n
Telehealth \/ Virtual care<\/strong><\/p>\nCompanies providing virtual services are becoming the standard of care in this environment as providers are limiting in-person visits to acute, emergency cases.<\/p>\n
Home health<\/strong><\/p>\nCompanies providing in-home care have seen volume increase as self-quarantine becomes more pervasive across the country and the globe.<\/p>\n
He says that before COVID-19, usage of telehealth services was estimated to be in the single digits in the US – largely in the areas of mental health. However, according to a survey from IMS Health (US healthcare data provider) – telehealth services used by clinicians surged past 50% in April.
\n<\/strong><\/p>\nAlso, US Government Medicare insurance (reimbursement) rules have already broadened to include various telehealth services. This ensures Medicare insurance will pay for virtual care now. Post-COVID, analysts expect hospitals to shift a larger volume of patient care to telehealth.<\/p>\n
Anthony Ginsberg said \u201cDigital health technologies could see accelerated adoption. Digital pharmacies could deliver opportunities for investors, and major e-commerce companies will likely speed up entry into the health-care marketplace.\u201d<\/strong><\/p>\nIn summary, the WELL ETF founder says key future Healthcare changes that will fuel growth in innovative Healthtech companies include:<\/p>\n
\n- An explosion of telehealth visits<\/strong><\/li>\n
- Remote inpatient consults and family visits<\/strong><\/li>\n
- Online scheduling and the automation of patient triage<\/strong><\/li>\n
- Artificial intelligence to allocate resources and make clinical decisions<\/strong><\/li>\n
- Supporting remote work and communication for team members<\/strong><\/li>\n
- Mobilizing teams to create PPE (equipment)<\/strong><\/li>\n
- Ensuring connectivity at remote COVID-19 testing sites and expanding capacity<\/strong><\/li>\n<\/ul>\n
Source: ETFWorld.co.uk<\/p>\n","protected":false},"excerpt":{"rendered":"
WELL ETF: Lessons learnt during Coronavirus crisis will fuel growth in the healthcare innovation sector. Anthony Ginsberg, Co-creator of the HAN-GINs Indxx Healthcare Innovation ETF (WELL) says the Coronavirus crisis has exposed many flaws in the US and other healthcare systems, which has proven a boost for innovative healthcare companies …<\/p>\n","protected":false},"author":4,"featured_media":21816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"telegram_tosend":false,"telegram_tosend_message":"","telegram_tosend_target":0,"footnotes":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_google_business_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[12],"tags":[200],"class_list":["post-21815","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-etf-analyse","tag-wisdomtree"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6}},"_links":{"self":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/21815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/comments?post=21815"}],"version-history":[{"count":1,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/21815\/revisions"}],"predecessor-version":[{"id":21817,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/21815\/revisions\/21817"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/media\/21816"}],"wp:attachment":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/media?parent=21815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/categories?post=21815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/tags?post=21815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}